Labor Market Pulse ArchiveSubscribe to a report

Labor Market Pulse · Life Sciences · October 2026

Life Sciences Labor Market Report: Bellingham, WA MSA — October 2026

Bellingham CRA pay climbs past national rate as scrutiny hits biostatistics.

Local Clinical Research Associate pay reached $97,556 versus $90,065 nationally, while Bellingham's Biostatistician median dropped sharply to $136,567 even as the national figure held flat.

Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.

Key indicators

  • CRA advertised pay, metro vs. national: $97,556 — vs $90,065 national median, both trending up
  • Biostatistician pay divergence: -significant (metro) — Metro $136,567 down sharply vs stable $131,958 national
  • Whatcom County unemployment: 3.6% — vs 4.5% metro-wide, 4.8% statewide (Sept)
  • National quit rate: 1.9% — Signals experienced staff staying put despite hiring demand

Key takeaways

Biostatistician pay drop looks like a sample-size story.

Metro median fell significantly to $136,567 while the national figure stayed flat at $131,958, an unusual divergence given Bellingham's small base of quantitative research employers. Treat this as a flag to verify posting volume before repricing offers for incumbent biostatisticians.

CRA compensation is pulling ahead of national pace.

Local CRA pay rose to $97,556, already above the $90,065 national median, consistent with the national narrative that experienced CRAs are the binding constraint on clinical trial capacity. Employers relying on in-house monitoring should expect continued upward pressure and weigh it against CRO monitoring rates.

Washington's wage floor keeps climbing, compressing entry-level lab bands.

State minimum wage rises to $17.73/hour in January 2027, a 3.5% bump that narrows the gap to Bellingham's $57,200 median Lab Technician pay. Compression at the entry tier may force a review of the full technician-to-associate scientist pay ladder, including rates above the starting tier.

Regulatory Affairs pay is flat locally while softening nationally.

Metro Regulatory Affairs Specialist pay held stable at $109,346 even as the national median slipped to $103,780, a gap consistent with reports of acute regulatory talent shortages tied to EUDAMED and EU AI Act compliance demands. Local employers may be absorbing this pressure through retention over new-hire pay growth, worth testing against actual offer data.

Median advertised pay by role — Bellingham, WA MSA

Life Sciences roles, October 2026. Source: WageScape.
Role25th percentileMedian advertised pay75th percentileMetro trendNational median
Research Scientist *$83,387$129,815$150,711Stable$130,339
Clinical Research Associate *$74,956$97,556$110,138Moderate increase$90,065
Lab Technician *$46,930$57,200$67,234Stable$47,840
Regulatory Affairs Specialist *$72,732$109,346$118,815Stable$103,780
Clinical Data Manager *$97,353$120,009$130,457Stable$123,653
Biostatistician *$110,345$136,567$158,319Significant decline$131,958
Validation Engineer *$93,560$113,771$124,081Stable$106,478

* State-level figure shown where metro postings were too few.

WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON

Local market conditions

Whatcom County unemployment held near 3.6% through summer before the broader Bellingham MSA registered 4.5% in August, a gap suggesting county-level labor supply remains tighter than metro-wide figures imply, particularly for credentialed roles. PeaceHealth and Western Washington University continue to anchor demand for scientific and clinical talent locally, while statewide life sciences employment has proven comparatively resilient to the layoff waves hitting Boston and San Diego biotech clusters.

What it means

Metro Biostatistician pay fell sharply this month even as the national median held flat, a divergence that may reflect thin local posting volume, a pattern worth distinguishing before resetting internal ranges. Clinical Research Associate advertised pay rose to $97,556 locally against $90,065 nationally, tracking the national CRA bottleneck and reinforcing that build-vs-outsource math favors CRO partnerships for incremental clinical capacity over local hires. Consider reviewing whether recent Biostatistician postings reflect a true metro repricing or a small-sample artifact before adjusting offer bands for that role.

Looking ahead

Worth watching: Washington's quit rate and the 1.9% national figure suggest experienced scientific and regulatory staff are staying in place; watch whether Bellingham employers see any uptick in voluntary departures as Q4 bonus and review cycles close.

Emerging pressure point: Washington sits atop the national WARN registry with 16,776 affected workers, though life sciences accounts for a small share of year-to-date filings. Monitor whether released talent from technology or manufacturing layoffs statewide begins appearing in Bellingham's scientific and technical candidate pool.

Early indicator: Biostatistician pay volatility this month warrants a follow-up check in November to confirm whether the metro figure stabilizes or confirms a lasting local repricing, before committing to any offer band changes.

Potential inflection point: Nearly a quarter of the national life sciences workforce is 55 or older; watch for any early retirement announcements among senior R&D or quality staff at PeaceHealth-affiliated or regional biotech employers that could accelerate succession planning timelines.

Sources

  1. Washington State Employment Security Department — Whatcom County unemployment at 3.6% in July 2026 vs 4.5% MSA in August
  2. Life sciences industry workforce research, 2026 — CRA talent shortage concentrated among experienced staff, not entry-level
  3. Washington Department of Labor & Industries — Washington minimum wage rising to $17.73/hour January 2027
  4. Life sciences industry workforce research, 2026 — EUDAMED and EU AI Act driving regulatory talent shortage
  5. Washington WARN Act tracker — Washington leads national WARN registry with 16,776 affected workers
  6. Bureau of Labor Statistics / biopharma industry survey — National quit rate at 1.9% amid biopharma hiring recovery

Methodology

Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.

Free to read and cite with attribution to WageScape. Terms of use.